Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ocular Therapeutix Company Profile (NASDAQ:OCUL)

Consensus Ratings for Ocular Therapeutix (NASDAQ:OCUL) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $45.67 (87.54% upside)

Analysts' Ratings History for Ocular Therapeutix (NASDAQ:OCUL)
Show:
DateFirmActionRatingPrice TargetActions
4/8/2015RBC CapitalLower Price TargetOutperform$50.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015OppenheimerBoost Price TargetOutperform$42.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015RBC CapitalBoost Price TargetOutperform$35.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015OppenheimerBoost Price TargetOutperform$25.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014OppenheimerInitiated CoverageOutperform$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014RBC CapitalInitiated CoverageOutperform$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2013 forward)